Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res May 1 2011 17 (9) 2603-2603;

CCR Translations

  • CCR Translations | Free Article
    Insulin Receptor Activation in Deletion 11q Chronic Lymphocytic Leukemia
    Jennifer R. Brown
    Clin Cancer Res May 1 2011 17 (9) 2605-2607; DOI:10.1158/1078-0432.CCR-11-0295

CCR New Strategies

  • CCR New Strategies
    New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
    Jay B. Shah, David J. McConkey and Colin P.N. Dinney
    Clin Cancer Res May 1 2011 17 (9) 2608-2612; DOI:10.1158/1078-0432.CCR-10-2770

Molecular Pathways

  • Molecular Pathways
    Aberrations of EZH2 in Cancer
    Andrew Chase and Nicholas C.P. Cross
    Clin Cancer Res May 1 2011 17 (9) 2613-2618; DOI:10.1158/1078-0432.CCR-10-2156

  • Molecular Pathways
    Direct Effects of Type I Interferons on Cells of the Immune System
    Sandra Hervas-Stubbs, Jose Luis Perez-Gracia, Ana Rouzaut, Miguel F. Sanmamed, Agnes Le Bon and Ignacio Melero
    Clin Cancer Res May 1 2011 17 (9) 2619-2627; DOI:10.1158/1078-0432.CCR-10-1114

Human Cancer Biology

  • Human Cancer Biology
    Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy
    Giulia Fregni, Aurélie Perier, Gianfranco Pittari, Simon Jacobelli, Xavier Sastre, Nadine Gervois, Mathilde Allard, Nadège Bercovici, Marie Françoise Avril and Anne Caignard
    Clin Cancer Res May 1 2011 17 (9) 2628-2637; DOI:10.1158/1078-0432.CCR-10-2084

  • Human Cancer Biology
    Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer
    Taishi Harada, Yasushi Yatabe, Masafumi Takeshita, Takaomi Koga, Tokujiro Yano, Yisong Wang and Giuseppe Giaccone
    Clin Cancer Res May 1 2011 17 (9) 2638-2645; DOI:10.1158/1078-0432.CCR-10-3034

  • Human Cancer Biology
    FUS-CREB3L2/L1–Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1
    Emely Möller, Jason L. Hornick, Linda Magnusson, Srinivas Veerla, Henryk A. Domanski and Fredrik Mertens
    Clin Cancer Res May 1 2011 17 (9) 2646-2656; DOI:10.1158/1078-0432.CCR-11-0145

  • Human Cancer Biology
    Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
    Hue-Kian Oh, Angie Lay-Keng Tan, Kakoli Das, Chia-Huey Ooi, Nian-Tao Deng, Iain BeeHuat Tan, Emmanuel Beillard, Julian Lee, Kalpana Ramnarayanan, Sun-Young Rha, Nallasivam Palanisamy, P. Mathijs Voorhoeve and Patrick Tan
    Clin Cancer Res May 1 2011 17 (9) 2657-2667; DOI:10.1158/1078-0432.CCR-10-3152

  • Human Cancer Biology
    Association of IFN-γ Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines
    Annedore Respa, Juergen Bukur, Soldano Ferrone, Graham Pawelec, Yingdong Zhao, Ena Wang, Francesco M. Marincola and Barbara Seliger
    Clin Cancer Res May 1 2011 17 (9) 2668-2678; DOI:10.1158/1078-0432.CCR-10-2114

  • Human Cancer Biology
    A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
    Kamlai Saiya-Cork, Roxane Collins, Brian Parkin, Peter Ouillette, Erlene Kuizon, Lisa Kujawski, Harry Erba, Erica Campagnaro, Kerby Shedden, Mark Kaminski and Sami N. Malek
    Clin Cancer Res May 1 2011 17 (9) 2679-2692; DOI:10.1158/1078-0432.CCR-10-2058

  • Human Cancer Biology
    Molecular Classification of Gastric Cancer: A New Paradigm
    Manish A. Shah, Raya Khanin, Laura Tang, Yelena Y. Janjigian, David S. Klimstra, Hans Gerdes and David P. Kelsen
    Clin Cancer Res May 1 2011 17 (9) 2693-2701; DOI:10.1158/1078-0432.CCR-10-2203

  • Human Cancer Biology
    Endogenous Axon Guiding Chemorepulsant Semaphorin-3F Inhibits the Growth and Metastasis of Colorectal Carcinoma
    Feng Wu, Qi Zhou, Jing Yang, Guang-jie Duan, Juan-juan Ou, Rong Zhang, Feng Pan, Qiu-ping Peng, Hong Tan, Yi-fang Ping, You-hong Cui, Cheng Qian, Xiao-chu Yan and Xiu-wu Bian
    Clin Cancer Res May 1 2011 17 (9) 2702-2711; DOI:10.1158/1078-0432.CCR-10-0839

  • Human Cancer Biology
    miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells
    Giorgio Zauli, Rebecca Voltan, Maria Grazia di Iasio, Raffaella Bosco, Elisabetta Melloni, Maria Elena Sana and Paola Secchiero
    Clin Cancer Res May 1 2011 17 (9) 2712-2724; DOI:10.1158/1078-0432.CCR-10-3244

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
    Naohiro Nishida, Koshi Mimori, Muller Fabbri, Takehiko Yokobori, Tomoya Sudo, Fumiaki Tanaka, Kohei Shibata, Hideshi Ishii, Yuichiro Doki and Masaki Mori
    Clin Cancer Res May 1 2011 17 (9) 2725-2733; DOI:10.1158/1078-0432.CCR-10-2132

  • Cancer Therapy: Preclinical
    Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
    Shirin Arastu-Kapur, Janet L. Anderl, Marianne Kraus, Francesco Parlati, Kevin D. Shenk, Susan J. Lee, Tony Muchamuel, Mark K. Bennett, Christoph Driessen, Andrew J. Ball and Christopher J. Kirk
    Clin Cancer Res May 1 2011 17 (9) 2734-2743; DOI:10.1158/1078-0432.CCR-10-1950

  • Cancer Therapy: Preclinical
    Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells
    Caroline H. Diep, Ruben M. Munoz, Ashish Choudhary, Daniel D. Von Hoff and Haiyong Han
    Clin Cancer Res May 1 2011 17 (9) 2744-2756; DOI:10.1158/1078-0432.CCR-10-2214

  • Cancer Therapy: Preclinical
    IL-4R Drives Dedifferentiation, Mitogenesis, and Metastasis in Rhabdomyosarcoma
    Tohru Hosoyama, Mohammed Imran Aslam, Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Joel E. Michalek, Lee Ann Zarzabal, Laura D. Nelon, Denis C. Guttridge, Brian P. Rubin and Charles Keller
    Clin Cancer Res May 1 2011 17 (9) 2757-2766; DOI:10.1158/1078-0432.CCR-10-3445

  • Cancer Therapy: Preclinical
    Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization
    Elizabeth J. Ilett, Montserrat Bárcena, Fiona Errington-Mais, Stephen Griffin, Kevin J. Harrington, Hardev S. Pandha, Matthew Coffey, Peter J. Selby, Ronald W.A.L. Limpens, Mieke Mommaas, Rob C. Hoeben, Richard G. Vile and Alan A. Melcher
    Clin Cancer Res May 1 2011 17 (9) 2767-2776; DOI:10.1158/1078-0432.CCR-10-3266

  • Cancer Therapy: Preclinical
    Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment
    Leslie S. Kurtzberg, Stephanie Roth, Roy Krumbholz, Jennifer Crawford, Christy Bormann, Sarah Dunham, Min Yao, Cecile Rouleau, Rebecca G. Bagley, Xian-Jie Yu, Fei Wang, Steven M. Schmid, Edmond J. LaVoie and Beverly A. Teicher
    Clin Cancer Res May 1 2011 17 (9) 2777-2787; DOI:10.1158/1078-0432.CCR-10-0542

  • Cancer Therapy: Preclinical | Free Article
    In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer
    Clement Mugabe, Yoshiyuki Matsui, Alan I. So, Martin E. Gleave, Jennifer H. E. Baker, Andrew I. Minchinton, Irina Manisali, Richard Liggins, Donald E. Brooks and Helen M. Burt
    Clin Cancer Res May 1 2011 17 (9) 2788-2798; DOI:10.1158/1078-0432.CCR-10-2981

  • Cancer Therapy: Preclinical | Free Article
    MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
    N.V. Rajeshkumar, Elizabeth De Oliveira, Niki Ottenhof, James Watters, David Brooks, Tim Demuth, Stuart D. Shumway, Shinji Mizuarai, Hiroshi Hirai, Anirban Maitra and Manuel Hidalgo
    Clin Cancer Res May 1 2011 17 (9) 2799-2806; DOI:10.1158/1078-0432.CCR-10-2580

  • Cancer Therapy: Preclinical
    Enhanced Safety Profiles of the Telomerase-Specific Replication- Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
    Kumiko Sugio, Fuminori Sakurai, Kazufumi Katayama, Katsuhisa Tashiro, Hayato Matsui, Kenji Kawabata, Atsushi Kawase, Masahiro Iwaki, Takao Hayakawa, Toshiyoshi Fujiwara and Hiroyuki Mizuguchi
    Clin Cancer Res May 1 2011 17 (9) 2807-2818; DOI:10.1158/1078-0432.CCR-10-2008

  • Cancer Therapy: Preclinical
    Epigenetic Modulation Enhances the Therapeutic Effect of Anti–IL-13Rα2 Antibody in Human Mesothelioma Xenografts
    Makoto Takenouchi, Sachie Hirai, Naoya Sakuragi, Hideo Yagita, Hirofumi Hamada and Kazunori Kato
    Clin Cancer Res May 1 2011 17 (9) 2819-2829; DOI:10.1158/1078-0432.CCR-10-2986

  • Cancer Therapy: Preclinical
    PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
    Roza Zandi, Galina Selivanova, Camilla Laulund Christensen, Thomas Alexander Gerds, Berthe Marie Willumsen and Hans Skovgaard Poulsen
    Clin Cancer Res May 1 2011 17 (9) 2830-2841; DOI:10.1158/1078-0432.CCR-10-3168

  • Cancer Therapy: Preclinical
    Prevention of Radiation-Induced Salivary Hypofunction Following hKGF Gene Delivery to Murine Submandibular Glands
    Changyu Zheng, Ana P. Cotrim, Anne Rowzee, William Swaim, Anastasia Sowers, James B. Mitchell and Bruce J. Baum
    Clin Cancer Res May 1 2011 17 (9) 2842-2851; DOI:10.1158/1078-0432.CCR-10-2982

  • Cancer Therapy: Preclinical
    Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
    Maria E. Balasis, Kara D. Forinash, Y. Ann Chen, William J. Fulp, Domenico Coppola, Andrew D. Hamilton, Jin Q. Cheng and Saïd M. Sebti
    Clin Cancer Res May 1 2011 17 (9) 2852-2862; DOI:10.1158/1078-0432.CCR-10-2544

  • Cancer Therapy: Preclinical
    Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
    Edmund Chiong, I-Ling Lee, Ali Dadbin, Anita L. Sabichi, Loleta Harris, Diana Urbauer, David J. McConkey, Rian J. Dickstein, Tiewei Cheng and H. Barton Grossman
    Clin Cancer Res May 1 2011 17 (9) 2863-2873; DOI:10.1158/1078-0432.CCR-09-3202

  • Cancer Therapy: Preclinical | Free Article
    Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer
    Filippa Pettersson, Christina Yau, Monica C. Dobocan, Biljana Culjkovic-Kraljacic, Hélène Retrouvay, Rachel Puckett, Ludmila M. Flores, Ian E. Krop, Caroline Rousseau, Eftihia Cocolakis, Katherine L. B. Borden, Christopher C. Benz and Wilson H. Miller Jr.
    Clin Cancer Res May 1 2011 17 (9) 2874-2884; DOI:10.1158/1078-0432.CCR-10-2334

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    The Viral Load of Epstein–Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
    Stefan Hohaus, Rosaria Santangelo, Manuela Giachelia, Barbara Vannata, Giuseppina Massini, Annarosa Cuccaro, Maurizio Martini, Valeriana Cesarini, Tonia Cenci, Francesco D'Alo, Maria Teresa Voso, Giovanni Fadda, Giuseppe Leone and Luigi M Larocca
    Clin Cancer Res May 1 2011 17 (9) 2885-2892; DOI:10.1158/1078-0432.CCR-10-3327

  • Imaging, Diagnosis, Prognosis
    Expression of nm23-H1 Is Associated with Poor Prognosis in Peripheral T-Cell Lymphoma, Not Otherwise Specified
    Nozomi Niitsu, Hirokazu Nakamine and Masataka Okamoto
    Clin Cancer Res May 1 2011 17 (9) 2893-2899; DOI:10.1158/1078-0432.CCR-10-2999

  • Imaging, Diagnosis, Prognosis
    Excellent Prognosis in a Subset of Patients with Ewing Sarcoma Identified at Diagnosis by CD56 Using Flow Cytometry
    Shifra Ash, Drorit Luria, Ian J. Cohen, Yacov Goshen, Helen Toledano, Josephine Issakov, Isaac Yaniv and Smadar Avigad
    Clin Cancer Res May 1 2011 17 (9) 2900-2907; DOI:10.1158/1078-0432.CCR-10-3069

  • Imaging, Diagnosis, Prognosis
    Digital Transcript Profile Analysis with aRNA-LongSAGE Validates FERMT1 As a Potential Novel Prognostic Marker for Colon Cancer
    Junwei Fan, Dongwang Yan, Mujian Teng, Huamei Tang, Chongzhi Zhou, Xiaoliang Wang, Dawei Li, Guoqiang Qiu and Zhihai Peng
    Clin Cancer Res May 1 2011 17 (9) 2908-2918; DOI:10.1158/1078-0432.CCR-10-2552

  • Imaging, Diagnosis, Prognosis
    The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors
    Heidi Rye Hudlebusch, Eric Santoni-Rugiu, Ronald Simon, Elisabeth Ralfkiær, Henrik Holm Rossing, Jens Vilstrup Johansen, Mette Jørgensen, Guido Sauter and Kristian Helin
    Clin Cancer Res May 1 2011 17 (9) 2919-2933; DOI:10.1158/1078-0432.CCR-10-1302

  • Imaging, Diagnosis, Prognosis | Free Article
    Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model
    Ranjana Mitra, Jinseon Lee, Jisuk Jo, Monica Milani, Jeanette N. McClintick, Howard J. Edenberg, Kenneth A. Kesler, Karen M. Rieger, Sunil Badve, Oscar W. Cummings, Ahmed Mohiuddin, Dafydd G. Thomas, Xianghua Luo, Beth E. Juliar, Lang Li, Clementina Mesaros, Ian A. Blair, Anjaiah Srirangam, Robert A. Kratzke, Clement J. McDonald, Jhingook Kim and David A. Potter
    Clin Cancer Res May 1 2011 17 (9) 2934-2946; DOI:10.1158/1078-0432.CCR-10-1803

  • Imaging, Diagnosis, Prognosis
    Comparative Prognostic Value of Epidermal Growth Factor Quantitative Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma
    Eirini Pectasides, Theodore Rampias, Panteleimon Kountourakis, Clarence Sasaki, Diane Kowalski, George Fountzilas, Thomas Zaramboukas, David Rimm, Barbara Burtness and Amanda Psyrri
    Clin Cancer Res May 1 2011 17 (9) 2947-2954; DOI:10.1158/1078-0432.CCR-10-2040

  • Imaging, Diagnosis, Prognosis
    Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes
    Hua Su, Nan Hu, Howard H. Yang, Chaoyu Wang, Mikiko Takikita, Quan-Hong Wang, Carol Giffen, Robert Clifford, Stephen M. Hewitt, Jian-Zhong Shou, Alisa M. Goldstein, Maxwell P. Lee and Philip R. Taylor
    Clin Cancer Res May 1 2011 17 (9) 2955-2966; DOI:10.1158/1078-0432.CCR-10-2724

  • Imaging, Diagnosis, Prognosis
    Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis
    Wolfgang Janni, Florian D. Vogl, Gro Wiedswang, Marit Synnestvedt, Tanja Fehm, Julia Jückstock, Elin Borgen, Brigitte Rack, Stephan Braun, Harald Sommer, Erich Solomayer, Klaus Pantel, Jahn Nesland, Klaus Friese and Bjørn Naume
    Clin Cancer Res May 1 2011 17 (9) 2967-2976; DOI:10.1158/1078-0432.CCR-10-2515

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Philip C. Amrein, Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, Kathleen M. Leahy, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Philippe Armand, Robert P. Hasserjian, Lillian Werner, Donna Neuberg and Jennifer R. Brown
    Clin Cancer Res May 1 2011 17 (9) 2977-2986; DOI:10.1158/1078-0432.CCR-10-2879

  • Cancer Therapy: Clinical
    Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
    Antoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, Begonya Comin-Anduix, David Lu, Michael Douek, Nagesh Ragavendra, Steve Raman, Elizabeth Seja, Darlene Rosario, Sabrina Miles, David C. Diamond, Zhiyong Qiu, Mihail Obrocea and Adrian Bot
    Clin Cancer Res May 1 2011 17 (9) 2987-2996; DOI:10.1158/1078-0432.CCR-10-3272

  • Cancer Therapy: Clinical
    Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies
    Glen J. Weiss, Jeffrey R. Infante, E. Gabriela Chiorean, Mitesh J. Borad, Johanna C. Bendell, Julian R. Molina, Raoul Tibes, Ramesh K. Ramanathan, Karen Lewandowski, Suzanne F. Jones, Mario E. Lacouture, Virginia K. Langmuir, Hank Lee, Stew Kroll and Howard A. Burris III
    Clin Cancer Res May 1 2011 17 (9) 2997-3004; DOI:10.1158/1078-0432.CCR-10-3425

  • Cancer Therapy: Clinical
    Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer
    Zara Ghazoui, Francesca M. Buffa, Anita K. Dunbier, Helen Anderson, Tim Dexter, Simone Detre, Janine Salter, Ian E. Smith, Adrian L. Harris and Mitchell Dowsett
    Clin Cancer Res May 1 2011 17 (9) 3005-3012; DOI:10.1158/1078-0432.CCR-10-1704

Predictive Biomarkers and Personalized Medicine

  • Predictive Biomarkers and Personalized Medicine
    The Role of Serum Immunoglobulin Free Light Chain in Response and Progression in Waldenstrom Macroglobulinemia
    Xavier Leleu, Wanling Xie, Meghan Bagshaw, Ranjit Banwait, Renee Leduc, Nitin Roper, Edie Weller and Irene M. Ghobrial
    Clin Cancer Res May 1 2011 17 (9) 3013-3018; DOI:10.1158/1078-0432.CCR-10-2954

  • Predictive Biomarkers and Personalized Medicine
    Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
    Alexandra Backshall, Rohini Sharma, Stephen J. Clarke and Hector C. Keun
    Clin Cancer Res May 1 2011 17 (9) 3019-3028; DOI:10.1158/1078-0432.CCR-10-2474

  • Predictive Biomarkers and Personalized Medicine | Free Article
    Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
    Rie Hamano, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Johji Hara, Jeong ho Moon, Kiyokazu Nakajima, Shuji Takiguchi, Yoshiyuki Fujiwara, Masaki Mori and Yuichiro Doki
    Clin Cancer Res May 1 2011 17 (9) 3029-3038; DOI:10.1158/1078-0432.CCR-10-2532

  • Predictive Biomarkers and Personalized Medicine
    Pretreatment Transcriptional Profiling for Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma
    Kate H. Brettingham-Moore, Cuong P. Duong, Danielle M. Greenawalt, Alexander G. Heriot, Jason Ellul, Christopher A. Dow, William K. Murray, Rodney J. Hicks, Joe Tjandra, Michael Chao, Andrew Bui, Daryl Lim Joon, Robert J. S. Thomas and Wayne A. Phillips
    Clin Cancer Res May 1 2011 17 (9) 3039-3047; DOI:10.1158/1078-0432.CCR-10-2915

Letters to the Editor

  • Letters to the Editor
    Reporting the Capture Efficiency of a Filter-Based Microdevice: A CTC Is Not a CTC Unless It Is CD45 Negative—Letter
    Gerhardt Attard, Mateus Crespo, Ai Chiin Lim, Lorna Pope, Andrea Zivi and Johann S. de Bono
    Clin Cancer Res May 1 2011 17 (9) 3048-3049; DOI:10.1158/1078-0432.CCR-10-3234

  • Letters to the Editor
    Reporting the Capture Efficiency of a Filter-Based Microdevice: A CTC Is Not a CTC Unless It Is CD45 Negative—Response
    Anthony Williams, Henry Lin, Ram Datar and Richard J. Cote
    Clin Cancer Res May 1 2011 17 (9) 3050-3050; DOI:10.1158/1078-0432.CCR-11-0512

Back to top
PreviousNext
Clinical Cancer Research: 17 (9)
May 2011
Volume 17, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
  • Direct Effects of Type I Interferons on Cells of the Immune System
  • A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
  • Prevention of Radiation-Induced Salivary Hypofunction Following hKGF Gene Delivery to Murine Submandibular Glands

Jump to

  • Highlights
  • CCR Translations
  • CCR New Strategies
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Predictive Biomarkers and Personalized Medicine
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement